WuXi AppTec Co., Ltd. (HKG:2359)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
70.45
-1.75 (-2.42%)
Jun 5, 2025, 3:45 PM HKT
99.29%
Market Cap 203.80B
Revenue (ttm) 42.45B
Net Income (ttm) 11.99B
Shares Out n/a
EPS (ttm) 3.48
PE Ratio 17.00
Forward PE 15.20
Dividend 1.43 (2.03%)
Ex-Dividend Date May 15, 2025
Volume 4,670,863
Average Volume 5,983,251
Open 72.60
Previous Close 72.20
Day's Range 69.90 - 73.00
52-Week Range 27.50 - 76.00
Beta 0.74
RSI 61.34
Earnings Date Jul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ... [Read more]

Sector Healthcare
Founded 2000
Employees 39,414
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2359
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.